Eclipse Surgical PTMR PMA Application Planned For Fourth Quarter
This article was originally published in The Gray Sheet
Eclipse Surgical Technologies is planning a fourth-quarter premarket approval application submission to FDA for its minimally invasive percutaneous transmyocardial revascularization (PTMR) holmium laser system for treatment of angina patients not amenable to conventional treatment.
You may also be interested in...
Shipments of Eclipse Surgical Technologies' Eclipse 2000 transmyocardial revascularization laser system began "immediately" following FDA approval, announced Feb. 11, at a price of $295,000 each, according to the firm.
Target guests in selected locations will be able to shop a curated Ulta Beauty section in the second half of 2021. The partnership could attract new clientele to Target stores and give Ulta a boost following nationwide store closures this year due to COVID.
COVID-19 Vaccines: ACIP’s Allocation Proposal Prioritizes Long-Term Care Residents, Essential Workers
First group to receive vaccine would comprise health care personnel and residents of long-term care facilities; next in line are non-health care essential workers, who would take priority over adults with high-risk medical conditions and those ages 65 years and older, according to the CDC advisory committee’s proposed allocation framework.